Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer - Concepedia

Concepedia

Publication | Open Access

Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer

DOI Full Paper Access

135

Citations

28

References

2019

Year

Yanjing Li, Yiping He, William Butler, Lingfan Xu, Yan Chang, Kefeng Lei, Hong Zhang, Yinglu Zhou, Allen C. Gao, Qingfu Zhang,

Science Translational Medicine

Abstract

Cellular heterogeneity of PCa contributes to hormonal therapy failure, but CXCR2 on neuroendocrine cells is a potential therapeutic target.

References

	Year	Citations

Page 1